Wh. Thompson et al., CONTROLLED TRIAL OF ORAL PREDNISONE IN OUTPATIENTS WITH ACUTE COPD EXACERBATION, American journal of respiratory and critical care medicine, 154(2), 1996, pp. 407-412
Citations number
35
Categorie Soggetti
Emergency Medicine & Critical Care","Respiratory System
Corticosteroids are often used in the outpatient treatment of acute ex
acerbation of chronic obstructive pulmonary disease (COPD). To date, t
here are few data documenting the benefit of this practice. The object
ive of this randomized, double-blind, placebo-controlled trial was to
assess the efficacy of corticosteroids in the outpatient treatment of
COPD exacerbations. Twenty-seven patients presenting with acute COPD e
xacerbation were studied. In addition to continuing their previous med
ications and increasing their use of beta-agonists, patients were rand
omized to receive a 9-d tapering dose of either oral prednisone or pla
cebo. Treatment with prednisone rather than placebo resulted in a more
rapid improvement in arterial PO2 (Pa-O2) (1.12 mm Hg/d versus -0.03
mm Hg/day; p = 0.002), alveolar-arterial oxygen gradient (A-aD(O2)) (-
1.16 mm Hg/d versus -0.03 mm Hg/day; p = 0.04), FEV(1) (0.05 L/d versu
s 0.00 L/d; p = 0.006), and peak expiratory flow (PEF) (0.15 L/s/d ver
sus 0.04 L/s/d; p = 0.009). Prednisone also resulted in fewer treatmen
t failures (p = 0.002) and in a trend toward more rapid improvement in
dyspnea scale scores. Outpatient treatment of acute COPD exacerbation
with prednisone accelerates recovery of Pa-O2, A-aDo(2), FEV(1), and
PEF, reduces the treatment failure rate, and improves subjective dyspn
ea.